← Back to Search

Orthopedic Implant

Enrolled Subjects for Total Knee Replacement

N/A
Waitlist Available
Research Sponsored by Exactech
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up annually through study completion, maximum of 10-years
Awards & highlights
No Placebo-Only Group

Summary

A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~annually through study completion, maximum of 10-years
This trial's timeline: 3 weeks for screening, Varies for treatment, and annually through study completion, maximum of 10-years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hospital for Special Surgery Knee Score
Knee Society Score
Oxford Knee Score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Enrolled SubjectsExperimental Treatment1 Intervention
Patients recruited from the population undergoing knee arthroplasty as part of standard of care. Patients who meet all the inclusion criteria and none of the exclusion criteria should be presented with an opportunity to undergo the informed consent process.

Find a Location

Who is running the clinical trial?

ExactechLead Sponsor
15 Previous Clinical Trials
25,788 Total Patients Enrolled
~1869 spots leftby Dec 2033
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top